Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (46)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by ARON, J. L
Right arrow Articles by PROROK, P. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ARON, J. L
Right arrow Articles by PROROK, P. C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

An Analysis of the Mortality Effect in a Breast Cancer Screening Study

JOAN L ARON* and PHILIP C PROROK{dagger}

* Biostatistics Branch, Landow 8C25, National Cancer Institute Bethesda, MD 20205, USA
{dagger} Biometry Branch, Blair 3A01, National Cancer Institute Bethesda, MD 20205. USA

Present address: Department of Population Dynamics, Johns Hopkins School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.

In order to better understand the effect of breast cancer screening on mortality, we use the theory of competing risks to analyse deaths from the long-term follow-up of the HIP breast cancer screening trial. We conclude that some, but not all, of the breast cancer cases detected early as a result of screening realized a benefit in terms of elimination of the risk of breast cancer mortality. Breast cancer screening appears not to affect the rate of mortality from causes of death other than breast cancer. Methodologically, we demonstrate the importance of analysing mortality separately for the breast cancer as well as for the entire population in a trial.

Revised 1 April 1985


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
C. I. Henschke and D. F. Yankelevitz
CT Screening for Lung Cancer: Update 2007
Oncologist, January 1, 2008; 13(1): 65 - 78.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
P. C Gotzsche
On the benefits and harms of screening for breast cancer
Int. J. Epidemiol., February 1, 2004; 33(1): 56 - 64.
[Full Text] [PDF]


Home page
Ann OncolHome page
A. Hackshaw
EUSOMA review of mammography screening
Ann. Onc., August 1, 2003; 14(8): 1193 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Stat Methods Med ResHome page
R. D Etzioni, R. J Connor, P. C Prorok, and S. G Self
Design and analysis of cancer screening trials
Statistical Methods in Medical Research, March 1, 1995; 4(1): 3 - 17.
[Abstract] [PDF]


Home page
Stat Methods Med ResHome page
T. O'Neill, G. Tallis, and P. Leppard
A review of the technical features of breast cancer screening illustrated by a specific model using South Australian cancer registry data
Statistical Methods in Medical Research, March 1, 1995; 4(1): 55 - 72.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.